Legal status · United States
Is Insulin legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Insulin is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 8 human studies are cited on its profile.
Insulin in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Analogue insulins are Prescription. Several older human insulin presentations, including HUMULIN R and NOVOLIN R, are listed Over-the-counter in Drugs@FDA as of 11 September 2026, which is why insulin can be bought without a prescription in some US pharmacies. That availability is a large part of how misuse happens. |
| FDA approval status | Approved and in wide use. Verified on 11 September 2026 through openFDA: HUMULIN R (recombinant human insulin, BLA 018780, Lilly) approved 28 October 1982; HUMALOG (insulin lispro, BLA 020563) approved 14 June 1996; LANTUS (insulin glargine, BLA 021081) approved 20 April 2000; TRESIBA (insulin degludec, BLA 203314) approved 25 September 2015; AFREZZA (inhaled insulin, BLA 022472) approved 27 June 2014. Some human insulin presentations, including HUMULIN R and NOVOLIN R vials, are listed Over-the-counter in Drugs@FDA; the analogues are Prescription. |
| Human studies cited | 8 of 10 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Insulin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Insulin for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Insulin is
The hormone that keeps people with type 1 diabetes alive, and the most thoroughly trialled peptide in medicine. Its randomised record is equally clear about the costs: severe hypoglycaemia at 1.00 versus 0.31 events per 100 person-years in a 12,537 person trial, and weight gain of 1.6 kg where the control group lost 0.5 kg.
Insulin is a two-chain peptide hormone, an A chain of 21 amino acids and a B chain of 30 held together by disulfide bonds, secreted by pancreatic beta cells. Every compound on this site that improves glucose control is measured against what insulin does.
Mechanism: In humans, insulin binds the insulin receptor, a receptor tyrosine kinase, driving glucose uptake into muscle and fat, suppressing hepatic glucose output, promoting glycogen and triglyceride storage and inhibiting lipolysis. At high concentrations it also cross-activates the IGF-1 receptor, which is the pharmacological basis for the anabolic claims made by people who misuse it and also the reason those doses are dangerous.
Regulatory history: Approved and in wide use. Verified on 11 September 2026 through openFDA: HUMULIN R (recombinant human insulin, BLA 018780, Lilly) approved 28 October 1982; HUMALOG (insulin lispro, BLA 020563) approved 14 June 1996; LANTUS (insulin glargine, BLA 021081) approved 20 April 2000; TRESIBA (insulin degludec, BLA 203314) approved 25 September 2015; AFREZZA (inhaled insulin, BLA 022472) approved 27 June 2014. Some human insulin presentations, including HUMULIN R and NOVOLIN R vials, are listed Over-the-counter in Drugs@FDA; the analogues are Prescription.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Insulin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Insulin in other countries
Frequently asked questions
Is Insulin legal in the United States?
Yes. Insulin is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 8 human studies are cited on its profile. Note: Analogue insulins are Prescription. Several older human insulin presentations, including HUMULIN R and NOVOLIN R, are listed Over-the-counter in Drugs@FDA as of 11 September 2026, which is why insulin can be bought without a prescription in some US pharmacies. That availability is a large part of how misuse happens.
Can I buy Insulin in the United States?
Only with a prescription. Insulin is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Analogue insulins are Prescription. Several older human insulin presentations, including HUMULIN R and NOVOLIN R, are listed Over-the-counter in Drugs@FDA as of 11 September 2026, which is why insulin can be bought without a prescription in some US pharmacies. That availability is a large part of how misuse happens.
Is Insulin FDA approved?
Yes. FDA status: Approved and in wide use. Verified on 11 September 2026 through openFDA: HUMULIN R (recombinant human insulin, BLA 018780, Lilly) approved 28 October 1982; HUMALOG (insulin lispro, BLA 020563) approved 14 June 1996; LANTUS (insulin glargine, BLA 021081) approved 20 April 2000; TRESIBA (insulin degludec, BLA 203314) approved 25 September 2015; AFREZZA (inhaled insulin, BLA 022472) approved 27 June 2014. Some human insulin presentations, including HUMULIN R and NOVOLIN R vials, are listed Over-the-counter in Drugs@FDA; the analogues are Prescription.. Current US classification: "FDA-approved, prescription only". On the evidence, 8 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Insulin live on its compound profile.
Insulin profileThis page is general information about the regulatory status of Insulin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.